Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Sports Medicine and Arthroscopy Review|May 3, 2014
The role of the scapula in throwing disordersCdr Matthew T Provencher, Amun Makani, John W McNeil, et al.British Journal of Cancer|September 15, 2001
Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicityC M Galmarini, N Falette, E Tabone, et al.British Journal of Cancer|July 20, 2007
Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cellsM Serova, C M Galmarini, A Ghoul, et al.BMC Cancer|February 8, 2017
Mechanism of action of trabectedin in desmoplastic small round cell tumor cellsS Uboldi, I Craparotta, G Colella, et al.British Journal of Cancer|December 4, 2015
Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedinB Colmegna, S Uboldi, R Frapolli, et al.British Journal of Pharmacology|October 28, 2010
PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activityJ F M Leal, M Martínez-Díez, V García-Hernández, et al.Molecular Biology of the Cell|October 12, 2022
Depletion of COPI in cancer cells: the role of reactive oxygen species in the induction of lipid accumulation, noncanonical lipophagy and apoptosisA Gasparian, M Aksenova, D Oliver, et al.Oncogene|November 12, 2013
Mode of action of trabectedin in myxoid liposarcomasS Di Giandomenico, R Frapolli, E Bello, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancerA Poveda, J M Del Campo, I Ray-Coquard, et al.American Journal of Lifestyle Medicine|March 9, 2026
Meaning, Purpose, and Spirituality and Clinician Well-BeingLiana Lianov, Julie A Haizlip, Shailaja Bhatia, et al.Pageof 3